Vials should also be kept away from direct sunlight and excessive heat
In controlled research environments, the peptides within KLOW are commonly studied for their involvement in cell signaling pathways, peptide transport behavior, and peptide stability in combination
Some stability studies have found that properly formulated compounded tirzepatide retains over 95% potency for 120 days under consistent refrigeration
The KLOW protocol refers to a researcher's defined experimental design specifying reconstitution volume, aliquot size, storage conditions, and application method in the laboratory model
1 Most were issued on September 9, 2025, but the FDA continues to publish new letters
The lower the dose, the more important reconstitution accuracy becomes